|
MechanismH2 receptor antagonists |
Active Org.- |
|
Active Indication- |
Inactive Indication- |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Istituto de Angeli SRL
0 Patents (Medical) associated with Istituto de Angeli SRL
100 Deals associated with Istituto de Angeli SRL
100 Translational Medicine associated with Istituto de Angeli SRL